HRT CEO Dr. Hufford presents at the FDA’s Advisory Committee Meeting on the Availability Naloxone
The costs of heroin and naloxone: a tragic snapshot of the opioid crisis
Purdue Pharma L.P. to Fund Harm Reduction Therapeutics, Inc.’s Work to Develop Inexpensive, Over-the-Counter, Life-Saving Naloxone in the United States
HRT CEO Dr. Hufford presents at the Nicholas Hall Conference
